These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 32651640

  • 1. Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson's disease.
    Farombi EO, Awogbindin IO, Olorunkalu PD, Ogbuewu E, Oyetunde BF, Agedah AE, Adeniyi PA.
    Psychopharmacology (Berl); 2020 Nov; 237(11):3225-3236. PubMed ID: 32651640
    [Abstract] [Full Text] [Related]

  • 2. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS, Sindhu KM, Senthilkumar KS, Mohanakumar KP.
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [Abstract] [Full Text] [Related]

  • 3. Kolaviron ameliorates behavioural deficit and injury to striatal dopaminergic terminals via modulation of oxidative burden, DJ-1 depletion and CD45R+ cells infiltration in MPTP-model of Parkinson's disease.
    Farombi EO, Awogbindin IO, Owoeye O, Abah VO, Izomoh ER, Ezekiel IO.
    Metab Brain Dis; 2020 Aug; 35(6):933-946. PubMed ID: 32430695
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease.
    Farombi EO, Awogbindin IO, Farombi TH, Oladele JO, Izomoh ER, Aladelokun OB, Ezekiel IO, Adebambo OI, Abah VO.
    Neurotoxicology; 2019 Jul; 73():132-141. PubMed ID: 30930291
    [Abstract] [Full Text] [Related]

  • 5. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH, Kang NH, Niles LP.
    Brain Res; 2016 Feb 15; 1633():115-125. PubMed ID: 26740407
    [Abstract] [Full Text] [Related]

  • 6. Phenothiazine normalizes the NADH/NAD+ ratio, maintains mitochondrial integrity and protects the nigrostriatal dopamine system in a chronic rotenone model of Parkinson's disease.
    Tapias V, McCoy JL, Greenamyre JT.
    Redox Biol; 2019 Jun 15; 24():101164. PubMed ID: 30925294
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T.
    Neurochem Int; 2009 Dec 15; 55(8):760-7. PubMed ID: 19647776
    [Abstract] [Full Text] [Related]

  • 8. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M, Ellaithy A, Helmy B, El-Gamal M, Tantawy D, Mohamed M, Sheashaa H, Sobh M, Arias-Carrión O.
    CNS Neurol Disord Drug Targets; 2012 Nov 01; 11(7):836-43. PubMed ID: 23198691
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats.
    Teerapattarakan N, Benya-Aphikul H, Tansawat R, Wanakhachornkrai O, Tantisira MH, Rodsiri R.
    Phytomedicine; 2018 May 15; 44():65-73. PubMed ID: 29895494
    [Abstract] [Full Text] [Related]

  • 10. Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7.
    Wang X, Guan Q, Wang M, Yang L, Bai J, Yan Z, Zhang Y, Liu Z.
    Drug Des Devel Ther; 2015 May 15; 9():2553-63. PubMed ID: 26089639
    [Abstract] [Full Text] [Related]

  • 11. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
    Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME.
    Neurotox Res; 2016 Feb 15; 29(2):275-87. PubMed ID: 26607911
    [Abstract] [Full Text] [Related]

  • 12. Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats.
    Horst CH, Schlemmer F, de Aguiar Montenegro N, Domingues ACM, Ferreira GG, da Silva Ribeiro CY, de Andrade RR, Del Bel Guimarães E, Titze-de-Almeida SS, Titze-de-Almeida R.
    Neurochem Res; 2018 Nov 15; 43(11):2132-2140. PubMed ID: 30267378
    [Abstract] [Full Text] [Related]

  • 13. Sodium salicylate protects against rotenone-induced parkinsonism in rats.
    Madathil SK, Karuppagounder SS, Mohanakumar KP.
    Synapse; 2013 Aug 15; 67(8):502-14. PubMed ID: 23447126
    [Abstract] [Full Text] [Related]

  • 14. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents.
    Garabadu D, Agrawal N.
    Neuromolecular Med; 2020 Jun 15; 22(2):314-330. PubMed ID: 31916219
    [Abstract] [Full Text] [Related]

  • 15. N-acetylcysteine prevents rotenone-induced Parkinson's disease in rat: An investigation into the interaction of parkin and Drp1 proteins.
    Rahimmi A, Khosrobakhsh F, Izadpanah E, Moloudi MR, Hassanzadeh K.
    Brain Res Bull; 2015 Apr 15; 113():34-40. PubMed ID: 25732239
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May 15; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective efficacy of the glucocorticoid receptor modulator PT150 in the rotenone mouse model of Parkinson's disease.
    Latham AS, Rocha SM, McDermott CP, Reigan P, Slayden RA, Tjalkens RB.
    Neurotoxicology; 2024 Jul 15; 103():320-334. PubMed ID: 38960072
    [Abstract] [Full Text] [Related]

  • 18. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H, Jia L, Chen X, Shi L, Xie J.
    Brain Res Bull; 2018 Mar 15; 137():132-139. PubMed ID: 29174294
    [Abstract] [Full Text] [Related]

  • 19. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.
    Sherer TB, Kim JH, Betarbet R, Greenamyre JT.
    Exp Neurol; 2003 Jan 15; 179(1):9-16. PubMed ID: 12504863
    [Abstract] [Full Text] [Related]

  • 20. Apelin-13 Protects Dopaminergic Neurons against Rotenone-Induced Neurotoxicity through the AMPK/mTOR/ULK-1 Mediated Autophagy Activation.
    Chen P, Wang Y, Chen L, Song N, Xie J.
    Int J Mol Sci; 2020 Nov 08; 21(21):. PubMed ID: 33171641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.